converting between glp-1 agonists Strategies to Enhance the Therapeutic Efficacy of GLP‐1 Receptor through Structural Modification and Carrier Delivery - Zhang - 2025 - ChemBioChem Glucagon-Like Peptide-1: New Regulator in
Description
What researchers know about GLP-1s and breast cancer McDonald presented her findings at the American Society of Clinical Oncology meeting, and the study was published June 2 in the medical journal JCO Oncology Practice
11 A study has shown that GLP-1Rs are increased in the visceral adipose tissue of morbidly obese patients with insulin resistance
Pre-clinical data demonstrate attenuation of inflammation, preservation of epithelial integrity, and modulation of the microbiome in colitis models
Diabetes in Control
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use
GLP-1 drugs were associated with a lower incidence of ten OACs compared to insulin
